Publications by authors named "Annedore Strnad"

Claim this Profile
E
Evidence for improved survival with bevacizumab treatment in recurrent high-grade gliomas: a retrospective study with ("pseudo-randomized") treatment allocation by the health insurance provider.
Susanne Hofmann, Manuel Alexander Schmidt, Thomas Weissmann, Ilker Eyüpoglu, Annedore Strnad

J Neurooncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulations in the Peripheral Immune System of Glioblastoma Patient Is Connected to Therapy and Tumor Progression-A Case Report from the IMMO-GLIO-01 Trial.
Paul F Rühle, Nicole Goerig, Roland Wunderlich, Rainer Fietkau, Udo S Gaipl, Annedore Strnad

Front Neurol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary glioblastoma multiforme tumors and recurrence : Comparative analysis of the danger signals HMGB1, HSP70, and calreticulin.
Carolin Muth, Yvonne Rubner, Sabine Semrau, Paul-Friedrich Rühle, Benjamin Frey, Annedore Strnad

Strahlenther Onkol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: Primary glioblastoma multiforme tumors and recurrence: comparative analysis of the danger signals HMGB1, HSP70, and calreticulin.
Carolin Muth, Yvonne Rubner, Sabine Semrau, Paul-Friedrich Rühle, Benjamin Frey, Annedore Strnad

Strahlenther Onkol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fractionated radiotherapy is the main stimulus for the induction of cell death and of Hsp70 release of p53 mutated glioblastoma cell lines.
Yvonne Rubner, Carolin Muth, Annedore Strnad, Anja Derer, Renate Sieber

Radiat Oncol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long term results of a prospective dose escalation phase-II trial: interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer.
Sebastian Lettmaier, Michael Lotter, Stephan Kreppner, Annedore Strnad, Rainer Fietkau, Vratislav Strnad

Radiother Oncol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis